Tipranavir is a non-peptidic protease inhibitor used in combination with ritonavir to treat human immunodeficiency virus (HIV) infection. The range of reference standards available for this compound is… Read more
![Chemical structure of [R-(R*,R*)]-3-[1-[3-[Bis(phenylmethyl)amino]phenyl]propyl]-5,6-dihydro-4-hydroxy-6-(2-phenylethyl)-6-(1-propynyl)-2H-pyran-2-one](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F188559-25-3-R-RR-3-1-3-Bisphenylmethylaminophenylpropyl-56-dihydro-4-hydroxy-6-2-phenylethyl-6-1-propynyl-2H-pyran-2-one.png&w=3840&q=75)




Tipranavir is a non-peptidic protease inhibitor used in combination with ritonavir to treat human immunodeficiency virus (HIV) infection. The range of reference standards available for this compound is essential for supporting rigorous pharmaceutical quality control and method validation. Laboratories utilize these high-quality materials, including impurities and degradation products, for accurate impurity profiling and to establish standardized testing protocols for manufacturing compliance. Furthermore, the inclusion of stable isotope labelled compounds, such as deuterium-labelled variants, provides critical internal standards for quantitative bioanalytical testing and pharmacokinetic studies. By employing these precise reference materials, researchers can reliably quantify tipranavir and identify related substances in complex matrices, ensuring the accuracy and reproducibility of analytical workflows throughout the drug development and regulatory approval process.